Actor Geoffrey Rush has been awarded at least $850,000 in damages after taking Nationwide News to court alleging it defamed him by tainting him as a sexual predator, with the judge calling the publisher’s conduct “improper and unjustified”.
Lawyers for a class action against the Federal Government-owned Airservices told a court Tuesday that higher salaries on individually negotiated management contracts did not leave managers better off than they would have been under relevant collective enterprise agreements.
A judge has rejected a bid by a group of Apache Corporation companies to break up a looming trial in a long-running dispute with WA-based oil and gas company Santos, saying holding a hearing on separate issues would not be the time saver Apache claims.
The judge overseeing the lengthy trial between agricultural giants Cargill and Viterra over the $420 million sale of malt producer Joe White has shot down Viterra’s request to shield the identity of malting companies that allegedly engaged in shady business practices, including using a banned substance to produce malt.
AMP will challenge the admissibility of an expert report central to ASIC’s case over alleged insurance churning by one of the wealth manager’s former financial advisers, after a judge called on the regulator to be more transparent about its communication with the experts in the case.
Trader Daniel Schlaepfer and his firm Select Vantage were alerted to possible market manipulation and flaws in the company’s surveillance system, the court has heard mid-trial in the case alleging ASIC made defamatory remarks to the trading firm’s major business partners.
Trader Daniel Schlaepfer and his firm Select Vantage are seeking over $10 million in damages from the Australian Securities and Investments Commission in a defamation action against the corporate regulator, a court heard Thursday on the fourth day of trial in the case.
The Australian Securities and Investments Commission made global trading firm Select Vantage “vanish overnight” from the Australian market using slanderous statements based on a lack of evidence, the NSW Supreme Court has heard.
The trial in a much anticipated shareholder class action against engineering firm WorleyParsons scheduled to commence this week has hit a roadblock, with a last minute change in the judge that will hear the matter.
The stakes will be high for the ACCC when the trial kicks off Monday in its case against Ramsay Health Care alleging the hospital giant misused its market power and engaged in exclusive dealing, after the competition regulator came up short in its last big misuse of market power case against pharmaceutical giant Pfizer.